| 90721-2 |
During the past Mo, how often did you eat a green leafy or lettuce salad, with or without other vegetables |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat a green leafy or lettuce salad, with or without other vegetables |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90721-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90722-0 |
During the past Mo, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90722-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90723-8 |
During the past Mo, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90723-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Arterial Stenosis; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90724-6 |
During the past Mo, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90724-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Count/time; f026; f26; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; Pig; Porcine; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES; Sus spp; Swine |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90725-3 |
During the past Mo, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90725-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Arterial Stenosis; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90726-1 |
During the past Mo, how often did you eat pizza |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat pizza |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90726-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90727-9 |
During the past Mo, how often did you eat any kind of cheese |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat any kind of cheese |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90727-9 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90728-7 |
During the past Mo, how often did you eat red meat, such as beef, pork, ham, or sausage |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat red meat, such as beef, pork, ham, or sausage |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90728-7 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Arterial Stenosis; Bos spp; Count/time; f026; f027; f26; f27; Last; month; nRate; Number rate; Number Rate = Count/Time; Pig; Porcine; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES; Sus spp; Swine |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 90729-5 |
During the past Mo, how often did you eat ice cream or other frozen desserts |
NRat |
^Patient |
1Mo |
Qn |
|
|
ACTIVE |
During the past month, how often did you eat ice cream or other frozen desserts |
|
ADD |
DefinitionDescription |
|
|
/mo |
|
|
|
|
|
|
SURVEY.NHANES |
|
90729-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
1 month; 1 month (30 days); 30 days; Count/time; Froz; Frozn; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES |
2.65 |
2.65 |
|
|
|
|
|
|
|
/mo |
|
|
|
0 |
| 9073-8 |
Potassium intake |
Sub |
^Patient |
Pt |
Qn |
Estimated |
|
ACTIVE |
Potassium intake Estimated |
|
MIN |
DefinitionDescription |
|
|
mol |
|
|
|
|
|
|
IO_IN_SALTS+CALS |
|
9073-8 |
|
Estimated |
|
|
|
|
|
|
0 |
Potassium intake Est |
|
|
|
|
|
Est; estimation; IO_INTAKE_SALTS+CALORIES; k; K+; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance amount |
2.48 |
1.0i |
|
|
|
|
|
|
|
mol |
|
|
|
0 |
| 90730-3 |
Self-perception of body weight |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Self-perception of body weight |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
90730-3 |
|
|
|
|
Observation |
|
|
|
0 |
Self-perception of body wgt |
|
PX230701020000 |
How do you describe your weight? |
|
|
Bdy weight; bod; Bodies; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Self-perception of body wgt; Wt |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90731-1 |
Frequency of creatine used to improve muscle mass or strength in past Y |
NRat |
^Patient |
1Y |
Ord |
|
|
ACTIVE |
Frequency of creatine used to improve muscle mass or strength in past year |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
90731-1 |
|
|
|
|
Observation |
|
|
|
0 |
Freq creatine used in past Y |
|
PX230801010000 |
In the past year, how often did you use any of the following products to improve muscle mass or strength? Creatine |
|
|
Count/time; Freq creatine used in past Y; H+P; H+P.HX; Last; Musc; Muscl; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90732-9 |
Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past Y |
NRat |
^Patient |
1Y |
Ord |
|
|
ACTIVE |
Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past year |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
90732-9 |
|
|
|
|
Observation |
|
|
|
0 |
Freq DHEA, A4 or hGH in past Y |
|
PX230801020000 |
In the past year, how often did you use any of the following products to improve muscle mass or strength? DHEA, Androstenedione, or human growth hormone |
|
|
Count/time; Freq DHEA, A4 or hGH in past Y; gamma-4-Androstenedione; H+P; H+P.HX; Horm; Last; Musc; Muscl; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90733-7 |
Frequency of anabolic steroids used to improve muscle mass or strength in past Y |
NRat |
^Patient |
1Y |
Ord |
|
|
ACTIVE |
Frequency of anabolic steroids used to improve muscle mass or strength in past year |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
90733-7 |
|
|
|
|
Observation |
|
|
|
0 |
Freq anabolic steroids used in past Y |
|
|
|
|
|
Anabolic steroid; Count/time; Freq anabolic steroids used in past Y; H+P; H+P.HX; Last; Musc; Muscl; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen; Ste; Steriods; Steroid |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90734-5 |
Body weight change goal |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Body weight change goal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
90734-5 |
|
|
|
|
Observation |
|
|
|
0 |
Body weight change goal |
|
|
|
|
|
Bdy weight; bod; Bodies; Exchange; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Replace; Wt |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90735-2 |
Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag Panel |
- |
Bld |
Pt |
- |
|
|
ACTIVE |
PNH GPI-Linked WBC and RBC Ag Panel - Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CELLMARK |
|
90735-2 |
|
|
|
|
Order |
|
|
|
0 |
PNH GPI-Lkd WBC + RBC Ag Pnl Bld |
|
|
|
|
|
Blood; CELL MARKERS; Glycosylphosphatidylinositol-linked proteins; Pan; PANEL.CELLMARK; Panl; Paroxysmal nocturnal hemoglobinuria; PLINK; PNH; PNH GPI-Linked WBC + RBC; PNH GPI-Lkd WBC + RBC Ag; PNH GPI-Lkd WBC + RBC Ag Pnl; Pnl; Point in time; Random; WB; Whole blood |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 90736-0 |
Cells.CD14-FLAER-/Cells.CD33 |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD14-FLAER- cells/Cells.CD33 (Monocytes) in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
90736-0 |
|
|
|
|
Both |
|
|
|
0 |
CD14-FLAER- cells/CD33 NFr Bld |
|
|
|
|
|
Blood; CD14 Cells; CD14-FLAER- cells; CD33 Cells; Cell; CELL MARKERS; Cellularity; Fluor 488-labeled mutant aerolysin; Glycosylphosphatidylinositol-linked proteins; gp67; LeuM3; Leu-M3; LeuM9; Leu-M9; LPS receptor; LPS-R; Mo2; Mo-2; My4; My-4; My9; My-9; Number fraction; p67; Paroxysmal nocturnal hemoglobinuria; Percent; PLINK; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.79 |
2.65 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; Release 2.72: LONG_COMMON_NAME: Added the cell type name to the display name to align with reference lab convention.; |
0 |
| 90737-8 |
Cells.CD24-FLAER-/Cells.CD15 |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD24-FLAER- cells/Cells.CD15 (Neutrophils) in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
90737-8 |
|
|
|
|
Both |
|
|
|
0 |
CD24-FLAER- cells/CD15 NFr Bld |
|
|
|
|
|
3-FAL; 3-FL; BA-1; Blood; CD15 Cells; CD24 Cells; CD24-FLAER- cells; Cell; CELL MARKERS; Cellularity; Fluor 488-labeled mutant aerolysin; Glycosylphosphatidylinositol-anchored protein; Heat stable antigen; HSA; Lacto-n-neo-fucopentaose III; LeuM1; Leu-M1; Lewis X; Lex; LNFP III; M-1; My1; My-1; Number fraction; Paroxysmal nocturnal hemoglobinuria; Percent; PLINK; PNH; Point in time; QNT; Quan; Quant; Quantitative; Random; SSEA-1; WB; Whole blood; X-hapten |
2.79 |
2.65 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; Release 2.72: LONG_COMMON_NAME: Added the cell type name to the display name to align with reference lab convention.; |
0 |
| 90738-6 |
Erythrocytes.CD59 complete loss/Cells.235a |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Erythrocytes.CD59 complete loss/Erythrocytes in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CELLMARK |
|
90738-6 |
|
|
|
|
Both |
|
|
|
0 |
RBC CD59 complete loss NFr |
|
|
|
|
|
Blood; CD59 RBC; Cell; CELL MARKERS; Cellularity; Discocytes; Erthrocyte; Erythrocyte; Glycosylphosphatidylinositol-anchored protein; Number fraction; Paroxysmal nocturnal hemoglobinuria; Percent; PLINK; PNH; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; RBCs CD59- comp loss; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood |
2.79 |
2.65 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 90739-4 |
Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag |
Imp |
Bld |
Pt |
Nar |
|
|
ACTIVE |
PHH GPI-Linked WBC and RBC Ag [Interpretation] in Blood Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
90739-4 |
|
|
|
|
Observation |
|
|
|
0 |
PNH GPI-Linked WBC + RBC Ag Bld-Imp |
|
|
|
|
|
Antigen; Antigens; Blood; CELL MARKERS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; PNH GPI-Linked WBC + RBC; PNH GPI-Lkd WBC + RBC Ag; Point in time; Random; Report; WB; Whole blood |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9074-6 |
Potassium intake |
Sub |
^Patient |
Pt |
Qn |
Measured |
|
ACTIVE |
Potassium intake Measured |
|
MIN |
DefinitionDescription |
|
|
mol |
|
|
|
|
|
|
IO_IN_SALTS+CALS |
|
9074-6 |
|
Measured |
|
|
|
|
|
|
0 |
Potassium intake Measured |
|
|
|
|
|
IO_INTAKE_SALTS+CALORIES; k; K+; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance amount |
2.48 |
1.0i |
|
|
|
|
|
|
|
mol |
|
|
|
0 |
| 90740-2 |
Aggressive prostate cancer risk |
Likelihood |
Ser/Plas |
Pt |
Qn |
Calculated.4Kscore |
|
ACTIVE |
Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
90740-2 |
|
Calculated.4Kscore |
|
|
Both |
|
|
|
0 |
Aggr PC risk SerPl Calculated.4Kscore |
|
|
|
|
|
Aggr PC risk; Calc; Calculation; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.65 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 90741-0 |
Parathyrin.1-84 |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
90741-0 |
|
IA |
|
|
Both |
|
|
|
0 |
Parathyrin.1-84 SerPl IA-mCnc |
|
|
|
|
|
Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; Level; Mass concentration; MEIA; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker |
2.65 |
2.65 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 90742-8 |
Bovine Mullerian inhibiting substance |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
FERT |
|
90742-8 |
|
IA |
|
|
Both |
|
|
|
0 |
Bovine MIS SerPl IA-mCnc |
|
|
|
|
|
AMH; Anti Mullerian hormone; Anti- M�¼llerian hormone; Anti-paramesonephric hormone; APH; Beef; Bovine MIS; EIA; ELFA; ELISA; Enzyme immunoassay; FERTILITY TESTING; IAA; Level; Mass concentration; MEIA; MIF; MIH; MIS; Mullerian inhibiting factor; Mullerian inhibiting hormone; M�¼llerian-inhibiting factor; M�¼llerian-inhibiting hormone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Subs; SUDS; Vet; Veterinary |
2.65 |
2.65 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 90743-6 |
CYBB gene full & NCF1 gene c.75_76delGT analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
90743-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
CYBB full + NCF1 c.75_76delGT Bld/T |
|
|
|
|
|
AMCBX2; Blood; CGD; CYBB full + NCF1 c.75_76delGT; CYBB gene full + NCF1 gene; cytochrome b-245, beta polypeptide; Cytochrome b-245, beta polypeptide (chronic granulomatous disease); Document; Finding; Findings; Genetics; GP91-1; GP91PHOX; GP91-PHOX; Heredity; Heritable; IMD34; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NCF-1; NCF1A; NCF-47K; neutrophil cytosolic factor 1; Neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1); NOX2; NOXO2; p47phox; p91-PHOX; PCR; Point in time; Random; SH3PXD1A; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
